This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yeh, T. F.
Right arrow Articles by Lien, Y. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeh, T. F.
Right arrow Articles by Lien, Y. J.
Related Collections
Right arrow Premature & Newborn

PEDIATRICS Vol. 101 No. 5 May 1998, p. e7

ELECTRONIC ARTICLE:
Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study

Received Sep 29, 1997; accepted Jan 5, 1998.

Tsu F. Yeh*, Yuh J. Lin*, Chao C. Huang*, Yung J. Chen*, Chyi H. Lin*, Hong C. LinDagger , Wu S. Hsieh§, and Yu J. Lien*

From the Departments of Pediatrics, * National Cheng Kung University Hospital, Tainan, ROC, Dagger  China Medical College Hospital, Taichung, ROC, and § Chang Gung Children's Hospital, Taipei, Taiwan, ROC.

Objectives.  To study the outcome at 2-year corrected age of infants who participated in a double-blind controlled trial of early (<12 hours) dexamethasone therapy for the prevention of chronic lung disease (CLD).

Methods and Materials.  A total of 133 children (70 in the control group, 63 in the dexamethasone-treated group) who survived the initial study period and lived to 2 years of age were studied. All infants had birth weights of 500 to 1999 g and had severe respiratory distress syndrome requiring mechanical ventilation within 6 hours after birth. For infants in the treatment group, dexamethasone was started at a mean age of 8.1 hours and given 0.25 mg/kg every 12 hours for 1 week and then tapered off gradually over a 3-week period. The following variables were evaluated: interim medical history, socioeconomic background, physical growth, neurologic examinations, mental and psychomotor development index score (MDI and PDI), pulmonary function, electroencephalogram, and auditory and visual evoked potential.

Results.  Infants in the control group tended to have a higher incidence of upper respiratory infection and rehospitalization than did the dexamethasone-treated group because of respiratory problems. Although there was no difference between the groups in somatic growth in girls, the dexamethasone-treated boys had significantly lower body weight and shorter height than the control boys (10.7 ± 3.0 vs 11.9 ± 2.0 kg; 84.9 ± 5.7 vs 87.5 ± 4.8 cm). The dexamethasone-treated group had a significantly higher incidence of neuromotor dysfunction (25/63 vs 12/70) than did the control group. The dexa-methasone-treated infants also had a lower PDI score (79 ± 26) than did the control group (87 ± 23), but the difference was not statistically significant. Both groups were comparable in MDI, incidence of vision impairment, and auditory and visual evoked potential. Significant handicap, defined as severe neurologic defect and/or intellectual defect (MDI and/or PDI <=  69), was seen in 22 children (31.4%) in the control group and 26 (41.2%) in the dexamethasone-treated group.

Conclusions.  Although early postnatal dexamethasone therapy for 4 weeks significantly reduces the incidence of CLD, this therapeutic regimen cannot be recommended at present because of its adverse effects on neuromotor function and somatic growth in male infants, detected at 2 years of age. A longer follow-up is needed. If early dexamethasone therapy is to be used for the prevention of CLD, the therapeutic regimen should be modified. The proper route of administration, the critical time to initiate the therapy, and the dosage and duration of therapy remain to be defined further.

Key words: preterm infant, early dexamethasone therapy, follow-up study.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. R. Neal Jr., G. Weidemann, M. Kabbaj, and D. M. Vazquez
Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R375 - R385.
[Abstract] [Full Text] [PDF]